Australian GP management of osteoarthritis following the release of the RACGP guideline for the non-surgical management of hip and knee osteoarthritis

被引:28
作者
Basedow M. [1 ,2 ]
Williams H. [3 ]
Shanahan E.M. [2 ,3 ]
Runciman W.B. [4 ,5 ,6 ]
Esterman A. [7 ,8 ]
机构
[1] School of Psychology, Social Work and Social Policy, University of South Australia, Adelaide, SA
[2] School of Medicine, Flinders University, Adelaide, SA
[3] Southern Adelaide Local Health Network, Adelaide, SA
[4] Australian Institute of Health Innovation, Macquarie University, Sydney, NSW
[5] Centre for Population Health Research, University of South Australia, Adelaide, SA
[6] Joanna Briggs Institute, University of Adelaide, Adelaide, SA
[7] Sansom Institute of Health Service Research, School of Nursing and Midwifery, University of South Australia, Adelaide, SA
[8] Centre for Chronic Disease Prevention, James Cook University, Cairns, QLD
基金
英国医学研究理事会;
关键词
General practitioners; Osteoarthritis; Primary health care;
D O I
10.1186/s13104-015-1531-z
中图分类号
学科分类号
摘要
Background: Osteoarthritis (OA) is a highly disabling and costly condition with an escalating prevalence in Australia due to the ageing and increasing obesity of the population. The general practitioner (GP) plays a central role in the management of this condition. The aim of this study was to examine opinions about the management of OA by Australian GPs following the release of the Royal Australian College of General Practitioners Guideline for the non-surgical management of hip and knee OA (RACGP OA CPG), and to compare the results with an earlier survey administered by the National Prescribing Service. Methods: In January 2013, a self-administered questionnaire was sent to 228 GPs to determine their treatment approaches to OA management using a clinical vignette of a patient with OA. This was compared with results from a similar survey undertaken in 2006. Results: Seventy-nine GPs returned questionnaires (response rate 35 %). GP recommendations for paracetamol, a paracetamol/codeine compound, and oral non-steroidal anti-inflammatory drugs (NSAIDs) were consistent with recommendations in the RACGP OA CPG, and varied little from the previous survey. Notably, there was a marked increase between surveys in GP recommendations for tramadol (p = 0.004) and more potent opioids (p < 0.001). Advice about the adverse effects of NSAIDs and codeine and how to manage them increased between surveys (p = 0.038 and 0.005, respectively). For all non-pharmacological treatments, there were only minor changes in the percentage of GP recommendations when compared with the previous survey, however they remain underutilised. Conclusions: GPs generally demonstrated a conservative approach to the treatment of OA, however, the increased recommendations for more potent opioids warrants further investigation. Patients should be made aware of the risks of medications through the use of decision aids, which can provide structured guidance to treatment. Non-pharmacological interventions were not given the importance that is suggested by clinical practice guidelines. © 2015 Basedow et al.
引用
收藏
相关论文
共 36 条
[21]
Zhang W., Nuki G., Moskowitz R.W., Abramson S., Altman R.D., Arden N.K., Bierma-Zeinstra S., Brandt K.D., Croft P., Doherty M., Et al., OARSI recommendations for the management of hip and knee osteoarthritis: part III: changes in evidence following systematic cumulative update of research published through January 2009, Osteoarthr Cartil, 18, pp. 476-499, (2010)
[22]
Marik P.E., Varon J., Omega-3 dietary supplements and the risk of cardiovascular events: a systematic review, Clin Cardiol, 32, pp. 365-372, (2009)
[23]
Bellamy N., Campbell J., Welch V., Gee T., Bourne R., Wells G., Intraarticular corticosteroid for treatment of osteoarthritis of the knee, Cochrane Database Syst Rev, (2006)
[24]
Brand C.A., The role of self-management in designing care for people with osteoarthritis of the hip and knee, Med J Aust, 189, pp. S25-S28, (2008)
[25]
Harris M.F., Jayasinghe U.W., Taggart J.R., Christl B., Proudfoot J.G., Crookes P.A., Et al., Multidisciplinary team care arrangements in the management of patients with chronic disease in Australian general practice, Med J Aust, 194, pp. 236-239, (2011)
[26]
Brosseau L., Yonge K.A., Robinson V., Marchand S., Judd M., Wells G., Et al., Thermotherapy for treatment of osteoarthritis, Cochrane Database Syst Rev, (2003)
[27]
Arthritis Research UK, Practitioner-based complementary and alternative therapies for the treatment of rheumatoid arthritis, osteoarthritis, fibromyalgia and low back pain, (2013)
[28]
Manheimer E., Cheng K., Linde K., Lao L., Yoo J., Wieland S., Et al., Acupuncture for peripheral joint osteoarthritis, Cochrane Database Syst Rev, (2010)
[29]
Alami S., Boutron I., Desjeux D., Hirschhorn M., Meric G., Rannou F., Et al., Patients' and practitioners' views of knee osteoarthritis and its management: a qualitative interview study, PLoS One, 6, (2011)
[30]
Sale J.E.M., Gignac M., Hawker G., How "bad" does the pain have to be? A qualitative study examining adherence to pain medication in older adults with osteoarthritis, Arthritis Care Res, 55, 2, pp. 272-278, (2006)